END STAGE RENAL DISEASE
Clinical trials for END STAGE RENAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new END STAGE RENAL DISEASE trials appear
Sign up with your email to follow new studies for END STAGE RENAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Facebook to the rescue: new app helps find Life-Saving organ donors
Disease control Recruiting nowThis study is testing a web-based app designed to help people waiting for a kidney or liver transplant. The app helps patients create and share their story on social media to find a living donor. The goal is to see if using social media makes it easier for patients to identify po…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Apr 01, 2026 20:12 UTC
-
New dialysis fluid aims to reduce sugar burden for kidney patients
Disease control Recruiting nowThis study is testing whether a new, low-glucose dialysis solution called XyloCore is as effective and safe as standard glucose-based solutions for people with end-stage kidney disease. About 170 patients who perform daily peritoneal dialysis at home will use either the new solut…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Iperboreal Pharma Srl • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for kidney transplant patients: drug aims to prevent early organ failure
Disease control Recruiting nowThis study is testing whether an investigational drug called pegcetacoplan can help prevent a common complication called delayed graft function (DGF) after a kidney transplant. DGF means the new kidney doesn't work right away, often requiring temporary dialysis. The trial will en…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Blood-Cleansing therapy trial offers hope for rare, agonizing skin condition
Disease control Recruiting nowThis study is testing whether a blood-filtering procedure called rheopheresis can help heal painful, hard-to-treat skin ulcers caused by calciphylaxis in people on dialysis. Researchers will compare the new treatment plus standard care against standard care alone in 138 patients.…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Mar 31, 2026 12:25 UTC
-
Heart-Saving drug showdown for dialysis patients
Disease control Recruiting nowThis study aims to find out which of two common blood pressure medications works better for people receiving dialysis. It will compare metoprolol, which is filtered out during dialysis, to carvedilol, which is not. The goal is to see which drug more effectively prevents heart att…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New kidney dialysis machine put to the test
Disease control Recruiting nowThis study is testing a new type of dialysis machine called the Solv System for people with end-stage kidney disease. It aims to see if the machine is safe and works as well as standard dialysis at cleaning the blood. The study will involve 46 people who receive their dialysis tr…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Medtronic - MITG • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New implant aims to make dialysis access last longer
Disease control Recruiting nowThis study is testing a small, external support device called VasQ that is placed around a surgically created blood vessel connection (fistula) used for dialysis. The goal is to see if the VasQ implant helps the fistula become ready for use faster and work better than the standar…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Laminate Medical Technologies • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Hope for kids with rare, devastating kidney disease
Disease control Recruiting nowThis study is testing an experimental drug called DCR-PHXC in children with a rare genetic disease called Primary Hyperoxaluria Type 1 (PH1) who have severe kidney damage or are on dialysis. The main goals are to see if the drug is safe and if it can lower harmful substances in t…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Could a common pill ease the strain of dialysis?
Disease control Recruiting nowThis study is testing if empagliflozin, a medication usually for diabetes, can help people who have just started kidney dialysis. Researchers want to see if it safely helps control body fluid levels and blood pressure in 60 adults. The goal is to see if this drug could improve ma…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Groundbreaking study tests HIV-Positive organ transplants for HIV patients
Disease control Recruiting nowThis study aims to learn about the safety and effectiveness of kidney transplants from donors with HIV to recipients who also have HIV. Researchers will follow 30 HIV-positive adults who need a kidney transplant and receive one from an HIV-positive donor. The goal is to gather kn…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Tulane University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New wrap aims to fix a major problem for dialysis patients
Disease control Recruiting nowThis study is testing a new, dissolvable wrap called SelfWrap that is placed around a surgically created blood vessel connection (fistula) used for dialysis. The goal is to see if the wrap helps the fistula develop properly and last longer while reducing complications, compared t…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: VenoStent • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New device could make dialysis access easier for kidney patients
Disease control Recruiting nowThis study is testing a medical device that creates a connection between an artery and vein for dialysis access using a minimally invasive approach. The research involves 280 adults with kidney failure who need dialysis. Doctors will track how well the access works for dialysis a…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
App aims to keep kidney patients out of the hospital
Disease control Recruiting nowThis study is testing whether a home monitoring system can help people with advanced kidney disease avoid emergency room visits and hospital stays. About 340 patients will use a tablet app to track their blood pressure, weight, and symptoms daily, sharing the data with their care…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University of Manitoba • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Boosting exercise power for dialysis patients: can a supplement help?
Disease control Recruiting nowThis study is testing if a combination of high-intensity exercise and a supplement called CoQ10 can improve muscle strength and energy levels in people with advanced kidney disease on dialysis. The goal is to see if this approach helps fight frailty and muscle loss better than ex…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New dialysis method aims to reduce fluid problems for kidney patients
Disease control Recruiting nowThis study is testing whether adjusting sodium levels during dialysis can help patients with end-stage kidney disease. Researchers want to see if this personalized approach reduces fluid weight gain between treatments and prevents dangerous blood pressure drops during dialysis. T…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Fresenius Medical Care Deutschland GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
VA tests smart fluid removal to make dialysis safer
Disease control Recruiting nowThis study is testing a new, personalized strategy for managing fluid in veterans on dialysis. It aims to see if using a patient's own recent blood pressure patterns to guide how much fluid is removed is better than the standard approach. The goal is to better control fluid overl…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New program aims to get kidney patients off the waitlist and into surgery
Disease control Recruiting nowThis study is testing a home-based support program for people waiting for a kidney transplant who are currently 'inactive' on the official waitlist. A team of a nurse, an occupational therapist, and a handyman will visit participants at home over four months to help them tackle p…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC
-
New ultrasound tech aims to make dialysis access safer and faster
Diagnosis Recruiting nowThis study is testing a new automated ultrasound system designed to help doctors monitor a special type of blood vessel connection (an arteriovenous fistula) used for dialysis in people with kidney failure. The goal is to see if using this device regularly can help the connection…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Sonavex, Inc. • Aim: Diagnosis
Last updated Mar 25, 2026 14:09 UTC
-
New ultrasound could spot hidden vein damage in dialysis
Diagnosis Recruiting nowThis study is testing if a special ultrasound probe placed inside a vein (IVUS) can give doctors a better picture of vein damage in people on dialysis. The goal is to see if this method is more accurate than the standard X-ray test (venogram) at finding and measuring blockages. R…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Boston Medical Center • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC
-
Can a simple supplement ease the exhaustion of dialysis?
Symptom relief Recruiting nowThis study is testing whether taking amino acid supplements during dialysis treatments can help reduce severe fatigue and improve strength and thinking skills in people with kidney failure. Researchers will compare two different supplement formulas in about 28 patients who receiv…
Matched conditions: END STAGE RENAL DISEASE
Phase: EARLY_PHASE1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Can simple symptom alerts give dialysis patients a better life?
Symptom relief Recruiting nowThis large French study is testing whether regularly asking dialysis patients about their symptoms and automatically alerting their care teams leads to better management and improved quality of life. It involves over 2,200 patients with kidney failure. One group will report sympt…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Central Hospital, Nancy, France • Aim: Symptom relief
Last updated Mar 27, 2026 12:37 UTC
-
Glowing glasses aim to fight dialysis fatigue
Symptom relief Recruiting nowThis study is testing whether wearing special light therapy glasses during dialysis treatments can help reduce severe fatigue in people with end-stage kidney disease. Researchers will compare bright light to dim light in 60 participants over four weeks. The main goal is to see if…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC
-
Magnets target dialysis Patients' debilitating back pain
Symptom relief Recruiting nowThis study is testing whether a treatment using magnetic stimulation can help reduce low back pain and prevent muscle loss in people with end-stage kidney disease who are on dialysis. Researchers will enroll 18 adult patients who experience significant back pain. The goal is to s…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Bundang CHA Hospital • Aim: Symptom relief
Last updated Mar 18, 2026 14:41 UTC
-
Massive study tracks 60,000 patients to unlock Heart-Kidney disease puzzle
Knowledge-focused Recruiting nowThis study is creating a large registry to track the health of 60,000 patients who have both chronic kidney disease and heart problems. The goal is to better understand how these conditions interact and affect patient outcomes like hospital readmissions and survival. By analyzing…
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Hidden danger: common diseases may make your medications more potent
Knowledge-focused Recruiting nowThis study aims to understand how chronic inflammatory diseases like type 2 diabetes, irritable bowel disease, and kidney failure might change how the body processes medications. Researchers will collect blood samples and health records from 150 patients with these conditions to …
Matched conditions: END STAGE RENAL DISEASE
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC
-
Listening to blood flow: can sounds predict dialysis access problems?
Knowledge-focused Recruiting nowThis study investigates whether sounds coming from dialysis fistulas can reveal problems with blood flow. Researchers will record sounds from 15 patients with kidney failure who need new dialysis access and compare them to detailed blood flow measurements. The goal is to understa…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC
-
First look: testing new drug safety in kidney patients
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a new drug called MK-2828 behaves in the bodies of people with kidney disease. Researchers will give a single dose to 24 participants, including people with severe kidney impairment and those on dialysis, and compare their drug levels…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:23 UTC